| Photodynamic therapy—current limitations and novel approaches G Gunaydin, ME Gedik, S Ayan Frontiers in Chemistry 9, 691697, 2021 | 372 | 2021 |
| Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status G Gunaydin, ME Gedik, S Ayan Frontiers in chemistry 9, 686303, 2021 | 305 | 2021 |
| A bifunctional photosensitizer for enhanced fractional photodynamic therapy: singlet oxygen generation in the presence and absence of light IS Turan, D Yildiz, A Turksoy, G Gunaydin, EU Akkaya Angewandte Chemie International Edition 55 (8), 2875-2878, 2016 | 263 | 2016 |
| Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs B Gok Yavuz, G Gunaydin, ME Gedik, K Kosemehmetoglu, D Karakoc, ... Scientific reports 9 (1), 3172, 2019 | 246 | 2019 |
| CAFs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion G Gunaydin Frontiers in oncology 11, 668349, 2021 | 127 | 2021 |
| Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset G Gunaydin, SA Kesikli, D Guc Oncoimmunology 4 (9), e1034918, 2015 | 59 | 2015 |
| Molecular demultiplexer as a terminator automaton IS Turan, G Gunaydin, S Ayan, EU Akkaya Nature Communications 9 (1), 805, 2018 | 56 | 2018 |
| Proof-of-principle for two-stage photodynamic therapy: hypoxia triggered release of singlet oxygen S Ayan, G Gunaydin, N Yesilgul-Mehmetcik, ME Gedik, O Seven, ... Chemical Communications 56 (94), 14793-14796, 2020 | 47 | 2020 |
| Mitochondria‐targeting selenophene‐modified BODIPY‐based photosensitizers for the treatment of hypoxic cancer cells O Karaman, T Almammadov, M Emre Gedik, G Gunaydin, S Kolemen, ... ChemMedChem 14 (22), 1879-1886, 2019 | 45 | 2019 |
| Amphiphilic Fullerene‐BODIPY Photosensitizers for Targeted Photodynamic Therapy EÖ Gündüz, ME Gedik, G Günaydın, E Okutan ChemMedChem 17 (6), e202100693, 2022 | 28 | 2022 |
| Granulocytic subset of myeloid derived suppressor cells in rats with mammary carcinoma Y Dolen, G Gunaydin, G Esendagli, D Guc Cellular immunology 295 (1), 29-35, 2015 | 25 | 2015 |
| Development of carboplatin loaded bovine serum albumin nanoparticles and evaluation of its effect on an ovarian cancer cell line O Esim, ME Gedik, AL Dogan, G Gunaydin, C Hascicek Journal of Drug Delivery Science and Technology 64, 102655, 2021 | 23 | 2021 |
| Immunometabolism–the role of branched-chain amino acids B Yahsi, G Gunaydin Frontiers in Immunology 13, 886822, 2022 | 16 | 2022 |
| Activation induced cytidine deaminase: An old friend with new faces E Çakan, G Gunaydin Frontiers in Immunology 13, 965312, 2022 | 14 | 2022 |
| Ductal carcinoma in situ and bilateral atypical ductal hyperplasia in a 23-year-old man with gynecomastia G Gunaydin, K Altundag The American Surgeon 77 (9), 1272-1273, 2011 | 13 | 2011 |
| The effects of cancer‐associated fibroblasts obtained from atypical ductal hyperplasia on anti‐tumor immune responses. B Gok Yavuz, G Gunaydin, K Kosemehmetoglu, D Karakoc, F Ozgur, ... Breast Journal 24 (6), 2018 | 10 | 2018 |
| NI-Bodipy-GO nanocomposites for targeted PDT E Öztürk Gündüz, B Tasasız, ME Gedik, G Günaydın, E Okutan ACS omega 8 (9), 8320-8331, 2023 | 7 | 2023 |
| BODIPY–GO nanocomposites decorated with a biocompatible branched ethylene glycol moiety for targeted PDT EÖ Gündüz, R Atajanov, ME Gedik, ET Eçik, G Günaydın, E Okutan Dalton Transactions 52 (17), 5466-5477, 2023 | 6 | 2023 |
| Effects of cellular energy homeostasis modulation through AMPK on regulation of protein translation and response to hypoxia G Gunaydin, ME Gedik Turkish Journal of Biochemistry 44 (5), 611-620, 2019 | 6 | 2019 |
| Can endocan serve as a molecular “hepatostat” in liver regeneration? SE Yazici, ME Gedik, CB Leblebici, K Kosemehmetoglu, G Gunaydin, ... Molecular Medicine 29 (1), 29, 2023 | 5 | 2023 |
Dicle GucHacettepe UniversityVerified email at hacettepe.edu.tr
